Vulnerability in Beckmancoulter Remisol Advance
CVE-2022-26235
A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.002 (7.6th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 8th percentile — 7.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: +0.000
Affected products
Weakness classification (CWE)
References
- www.beckmancoulter.com/products/clinical-information-management-tools/remisol-a… (Product, Vendor Advisory)
- pastebin.com/amgw9pE7 (Third Party Advisory)
Frequently asked questions
- What is CVE-2022-26235?
- CVE-2022-26235 is a high-severity vulnerability in Beckmancoulter Remisol Advance, classified under Incorrect Default Permissions. CVSS score: 7.8/10. Published 2022-10-06.
- How severe is CVE-2022-26235?
- High severity. CVSS v3 base score is 7.8 out of 10.